IL-12/IL-23 inhibitors: the advantages and disadvantages of this novel approach for the treatment of psoriasis.

Skin therapy letter

Volumn 13, Issue 8, 2008, Pages 1-4

  Bartlett, B L ^a   Moody, M N ^a   Tyring, S K ^a  

^a CENTER FOR CLINICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 874 ANTIBODY, HUMAN; ABT-874 ANTIBODY, HUMAN; INTERLEUKIN 12; INTERLEUKIN 23; MONOCLONAL ANTIBODY; USTEKINUMAB;

ARTICLE; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; PSORIASIS;

ANTIBODIES, MONOCLONAL; HUMANS; INTERLEUKIN-12; INTERLEUKIN-23; PSORIASIS;

EID: 67651048882     PISSN: 12015989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)